rethinkTHC Search
Menu
Study breakdown

One-third of cannabis-induced psychosis cases later develop schizophrenia

Meta AnalysisStrong evidence
The takeaway

A meta-analysis of 50 studies found that 34% of people with cannabis-induced psychosis eventually transitioned to schizophrenia, the highest rate among all substances.

Psychiatrists, emergency physicians evaluating acute psychosis, and early intervention clinicians.

34% transition from cannabis-induced psychosis to schizophrenia

What the researchers found

Across 50 studies encompassing 40,783 people, the pooled transition rate from substance-induced psychosis to schizophrenia was 25%. Cannabis had the highest substance-specific transition rate at 34% (95% CI 25-46%), followed by hallucinogens (26%) and amphetamines (22%). Alcohol (10%), opioids (12%), and sedatives (9%) had much lower rates.

Why it matters

This establishes that cannabis-induced psychosis is not just a temporary drug reaction. One in three affected individuals will develop schizophrenia, making it the substance most strongly associated with psychosis transition.

The numbers in context

50 studies; 40,783 people; overall transition 25%; cannabis 34% (6 studies); hallucinogens 26% (3 studies); amphetamines 22% (5 studies); alcohol 10%; opioids 12%; sedatives 9%.

How the study worked

Systematic review and meta-analysis of 50 studies from MEDLINE, PsychINFO, and Embase providing 79 estimates of transition from substance-induced psychosis to schizophrenia, including 43 substance-specific estimates.

What this study cannot tell us

Heterogeneity in how substance-induced psychosis was defined across studies; transition rates may reflect shared vulnerability rather than causation; older cohorts had slightly lower rates; publication bias possible.

How to read the evidence

Strong: large meta-analysis with 50 studies, robust methodology, and clear substance-specific comparisons.

When this study was published

Published 2020.

The bigger picture

This meta-analysis reframes cannabis-induced psychosis as a potential prodrome of schizophrenia rather than a benign, self-limited drug reaction. It argues for assertive psychiatric follow-up in anyone experiencing cannabis-related psychosis.

Questions still open

  • Can we identify which cannabis-induced psychosis patients will transition? Would early antipsychotic treatment after cannabis-induced psychosis prevent progression?

Common questions

Is cannabis-induced psychosis always temporary?
No. This meta-analysis found that 34% of people who experienced cannabis-induced psychosis eventually developed schizophrenia, making assertive psychiatric follow-up essential.
Which substances carry the highest risk of progressing to schizophrenia?
Cannabis had the highest transition rate (34%), followed by hallucinogens (26%) and amphetamines (22%). Alcohol (10%) and opioids (12%) had much lower rates.

Read the original research

Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis.

Schizophrenia bulletin, 46(3), 505-516

Citation

Murrie, Benjamin; Lappin, Julia; Large, Matthew; Sara, Grant. (2020). Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis.. Schizophrenia bulletin, 46(3), 505-516. https://doi.org/10.1093/schbul/sbz102

Explore the wider topic